Neurotoxicity of methamphetamine: Main effects and mechanisms.
Jayanthi S, Daiwile AP, Cadet JL.
Exp Neurol. 2021 Oct;344:113795. doi: 10.1016/j.expneurol.2021.113795. Epub 2021 Jun 26.
Methamphetamine psychosis: epidemiology and management.
Glasner-Edwards S, Mooney LJ.
CNS Drugs. 2014 Dec;28(12):1115-26. doi: 10.1007/s40263-014-0209-8.
Risk of Incident Psychosis and Mania With Prescription Amphetamines.
Moran LV, Skinner JP, Shinn AK, Nielsen K, Rao V, Taylor ST, Cohen TR, Erkol C, Merchant J, Mujica CA, Perlis RH, Ongur D.
Am J Psychiatry. 2024 Oct 1;181(10):901-909. doi: 10.1176/appi.ajp.20230329. Epub 2024 Sep 12.
Methamphetamine: Effects on the brain, gut and immune system.
Prakash MD, Tangalakis K, Antonipillai J, Stojanovska L, Nurgali K, Apostolopoulos V.
Pharmacol Res. 2017 Jun;120:60-67. doi: 10.1016/j.phrs.2017.03.009. Epub 2017 Mar 14.
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S.
N Engl J Med. 2019 Mar 21;380(12):1128-1138. doi: 10.1056/NEJMoa1813751.
Psychosis Risk With Prescription Amphetamine.
Tamminga CA.
Am J Psychiatry. 2024 Oct 1;181(10):856-857. doi: 10.1176/appi.ajp.20240732.
Stimulants and narcolepsy.
Mahowald MW, Bornemann MA.
Sleep. 2005 Jun;28(6):663. doi: 10.1093/sleep/28.6.663.
Methamphetamine-associated psychosis.
Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, Carlo G, Bevins RA.
J Neuroimmune Pharmacol. 2012 Mar;7(1):113-39. doi: 10.1007/s11481-011-9288-1. Epub 2011 Jul 5.
Opioid-induced neurotoxicity.
Matzo M, Dawson KA.
Am J Nurs. 2013 Oct;113(10):51-6. doi: 10.1097/01.NAJ.0000435351.53534.83.
Neurological Effects of Stimulants and Hallucinogens.
Hass RM, Stitt D.
Semin Neurol. 2024 Aug;44(4):459-470. doi: 10.1055/s-0044-1787572. Epub 2024 Jun 18.
